ILT tooth whitening laser placements will not be slowed by warning letter, firm says.
This article was originally published in The Gray Sheet
ION LASER TECHNOLOGY'S TOOTH WHITENING CENTER EQUIPMENT PLACEMENTS will not be delayed by a recent FDA warning letter citing violations of two of its tooth-whitening lasers, the company says in a June 26 release responding to the letter. ILT says the deficiencies are relatively minor, and that FDA has indicated that the firm can continue to ship products while corrections are made.
You may also be interested in...
China’s Bio-Thera Solutions has ventured outside of its domestic market for the first time by filing an application for a biosimilar version of Avastin with the European Medicines Agency. The company has also revealed its timeline for a submission to the FDA.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
Under EU rules, once a medicinal product has been placed on the market in a country of the EEA – the EU plus Iceland, Liechtenstein and Norway